Login / Signup

A high prevalence of neutrophil-specific antibodies in ELANE-mutated severe congenital neutropenia.

Weronika DobrewaJoanna MadzioKatarzyna Babol-PokoraPatrycja LopaczAgnieszka GierszonKatarzyna GuzAgnieszka OrzińskaMalgorzata UhrynowskaAleksandra JasinskaMaciej ZdunekWojciech MlynarskiSzymon Janczar
Published in: Pediatric blood & cancer (2023)
An assay for neutrophil-specific antibodies is frequently used in the workup of chronic severe neutropenia and is suggestive of autoimmune, or sporadically alloimmune neutropenia, rather than severe congenital neutropenia (SCN). We analyzed a neutropenia consortium database for the outcomes of antibody testing initiated before receiving genetic diagnosis in Polish SCN cohort. Test results, performed in a single reference laboratory, were available for 14 patients with ELANE-mutated SCN or cyclic neutropenia, and were frequently positive (36%). We note that the trigger for genetic studies in severe neutropenia should not be affected by antibody-positivity and should be clinically driven.
Keyphrases
  • chemotherapy induced
  • early onset
  • drug induced
  • multiple sclerosis
  • adipose tissue
  • high throughput
  • gene expression
  • skeletal muscle
  • electronic health record